Menu Search
Equities

Nanosonics Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
OQS:STU

Nanosonics Ltd

Actions
  • Price (EUR)2.06
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-0.96%
  • Beta1.6181
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. Its trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.

  • Revenue in AUD (TTM)198.63m
  • Net income in AUD20.68m
  • Incorporated2000
  • Employees470.00
  • Location
    Nanosonics Ltd7-11 Talavera Road, Macquarie ParkSYDNEY 2113AustraliaAUS
  • Phone+61 28063-1600
  • Fax+61 29418-3743
  • Websitehttps://www.nanosonics.com.au/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.